| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $130K | +54.8% | -57.4% |
| SG&A Expense | $1.3M | +24.3% | -62.0% |
| Operating Income | -$1.4M | -26.5% | +75.7% |
| Interest Expense | $0 | — | — |
| Pre-tax Income | -$1.4M | — | +76.0% |
| Income Tax | $0 | — | +100.0% |
| Net Income | -$1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.5M | -14.5% | -47.1% |
| Current Assets | $4.9M | -17.6% | -44.9% |
| Total Assets | $5.0M | -17.3% | -43.8% |
| Current Liabilities | $598K | +72.3% | -34.6% |
| Total Liabilities | $151.6M | +0.2% | -0.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.5M | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $635K | — | — |
| +75.1% |
| EPS (Basic) | -$0.01 | — | +90.0% |
| EPS (Diluted) | -$0.01 | — | +90.0% |
| -$149.2M |
| -0.9% |
| -4.3% |